Redefining the Standard of Care: The PROGRESS Trial Challenges the "Wait and See" Approach to Moderate Aortic Stenosis on November 3, 2026 Posted by
Decoding the Immune Stalemate: A New Frontier in Treating Chronic Diabetic Ulcers on November 3, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 3, 2026 Posted by
Beyond the Salt Shaker: Why Potassium is the Missing Link in Global Heart Health on November 3, 2026 Posted by
Navigating the Future of Nutrition: A Comprehensive Review of the 2022-2023 Healthy Living Landscape on November 3, 2026 Posted by
Redefining the Standard of Care: The PROGRESS Trial Challenges the "Wait and See" Approach to Moderate Aortic Stenosis on November 3, 2026 Posted by
Decoding the Immune Stalemate: A New Frontier in Treating Chronic Diabetic Ulcers on November 3, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 3, 2026 Posted by
Posted in Cardiovascular Recovery Rethinking Prevention: New Study Suggests Earlier Intervention for High-Risk Diabetes Patients Using PCSK9 Inhibitors on July 14, 2026
Posted in Cardiovascular Recovery The VESALIUS-CV Trial: Exploring PCSK9 Inhibition in High-Risk Primary Prevention on May 10, 2026 rifanmuazin
